Protagonist Therapeutics Inc (PTGX NASDAQ) stock market data APIs
$75.151
-1.18(-1.6%)
as of October 24, 2025
Try our APIs with
free plan!
Protagonist Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.
Prev. Close
75.151
Open
73.9663
High
75.6497
Low
73.7972
52 wk Range
33.31-93.2499
Market Cap
4 603 M
P/E Ratio
101.3493
Shares Outstanding
62 211 K
Revenue
209 M
EPS
-0.55
Beta
2.202
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Protagonist Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Protagonist Therapeutics Inc data using free add-ons & libraries
Get Protagonist Therapeutics Inc Fundamental Data
Protagonist Therapeutics Inc Fundamental data includes:
- Net Revenue: 209 M
- EBITDA: 24 868 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.58
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Protagonist Therapeutics Inc News
New
Moody Aldrich Dumps Entire Stake in Chart Industries Worth $5.8 Million
Key Points Exited 35,228 shares in Chart Industries. Estimated trade size: $5.8 million Represents a 1.1% change in the fund’s 13F reportable assets under management for the period ended Q3 2025 Po...
2 Top Dividend Kings Every Income Investor Should Own
Key Points Johnson & Johnson has one of the healthiest financial profiles in the world. PepsiCo backs its dividend with a rock-solid financial profile. Both companies have the financial fortitude t...
High Growth US Tech Stocks To Watch In October 2025
As of October 2025, the U.S. stock market has been experiencing significant volatility, with major indices like the Nasdaq and S&P 500 rebounding sharply after recent declines due to geopolitical tens...
Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal
Shares of Protagonist Therapeutics PTGX rose 30% on Friday following a report issued by the Wall Street Journal ("WSJ"), as cited in a Yahoo Finance article, which stated that pharma giant J&J JNJ is ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
